Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Fink

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Antimicrobial Agents and Chemotherapy|May 19, 2021
Erratum for Herring et al., "Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs"Shawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Journal of Natural Products|April 12, 2023
Modulation of <i>in Vitro</i> SARS-CoV-2 Infection by <i>Stephania tetrandra</i> and Its Alkaloid ConstituentsAswad Khadilkar, Zoie L Bunch, Jessica Wagoner, et al.
Journal of Clinical Microbiology|June 24, 2021
Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing ImmunityBenjamin T Bradley, Andrew Bryan, Susan L Fink, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
The Journal of Clinical Investigation|December 15, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidatesJim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
Critical Care (London, England)|April 20, 2021
Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort studyPavan K Bhatraju, Eric D Morrell, Leila Zelnick, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 24, 2022
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illnessEric D Morrell, Pavan K Bhatraju, Neha A Sathe, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Antimicrobial Agents and Chemotherapy|May 19, 2021
Erratum for Herring et al., "Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs"Shawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Journal of Natural Products|April 12, 2023
Modulation of <i>in Vitro</i> SARS-CoV-2 Infection by <i>Stephania tetrandra</i> and Its Alkaloid ConstituentsAswad Khadilkar, Zoie L Bunch, Jessica Wagoner, et al.
Journal of Clinical Microbiology|June 24, 2021
Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing ImmunityBenjamin T Bradley, Andrew Bryan, Susan L Fink, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
The Journal of Clinical Investigation|December 15, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidatesJim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
Critical Care (London, England)|April 20, 2021
Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort studyPavan K Bhatraju, Eric D Morrell, Leila Zelnick, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 24, 2022
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illnessEric D Morrell, Pavan K Bhatraju, Neha A Sathe, et al.
Pageof 6